Clin2
NCT06173778Possibly a fitRecruiting

Semaglutide for weight management after quitting smoking

ObesityOverweightCigarette Smoking

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests whether the drug semaglutide (often used for weight loss) can help people who quit smoking avoid gaining weight. It's for people who are overweight or have weight-related health issues and want to stop smoking.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
197 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must be at least 18 years old and willing to follow the study procedures.
  • You must have a high body weight (BMI of 30 or more, or 27 or more with a related health condition like high blood pressure or heart disease).
  • You must be a current smoker (at least 5 cigarettes a day for a year) and want to quit within the next month.
  • You cannot have diabetes, a history of pancreatitis, or certain thyroid or kidney conditions.
  • You cannot be using other tobacco products, weight loss medications, or smoking cessation aids at the start of the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.

NCT07465965Recruiting· Phase 1
Weight loss study of semaglutide nasal spray in overweight or obese adults

This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.

Secaucus, New Jersey
NCT07770841Recruiting· Phase 3
Oral medication for weight loss study

This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.

Birmingham, Alabama
NCT07767175Recruiting· Phase 1
Weight loss study for adults with overweight or obesity

This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.

Lenexa, Kansas
NCT07323134Not yet recruiting
Semaglutide and gut bacteria in people with obesity

This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.

NCT07154238Enrolling by invitation
Semaglutide for weight management: a real-world study

This study looks at the experiences of people using injectable semaglutide for weight loss, as well as the doctors who prescribe it. It aims to understand how the treatment works in everyday life.

Bad Oeynhausen

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.